dfp-10917
Small moleculeexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
3
Phase 3
1
Phase 4
0
Earliest trial started Sep 1, 2012 (NCT01702155)
Timeline
Indications
Mechanism of action
- DNA polymerase nuINHIBITOR
POLN inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- dfp-10917
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06382168 | Phase 1/Phase 2 (Phase 2) | Jun 12, 2024 | Delta-Fly Pharma, Inc. |
| NCT03926624 | Phase 3 | Apr 30, 2019 | Delta-Fly Pharma, Inc. |
| NCT01702155 | Phase 1/Phase 2 (Phase 2) | Sep 1, 2012 | Delta-Fly Pharma, Inc. |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Delta-Fly Pharma, Inc. | For profit | 3 | 3 | 2 | 2012 |
1 organizations
Page 1 / 1